At a glance
- Originator Kyowa Hakko
- Class Analgesics; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 26 May 2001 No-Development-Reported for Pain in Japan (Unknown route)
- 21 Sep 1998 Preclinical development for Pain in Japan (Unknown route)